Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck KGaA
Pharma
Merck KGaA's new CEO Beckmann emphasizes reliance on M&A
Merck KGaA is emphasizing the importance of M&A to stock its early- to mid-stage pharma pipeline, the company said on Wednesday.
Kevin Dunleavy
May 13, 2026 11:54am
Top 20 pharma companies by 2025 revenue
Apr 20, 2026 3:00am
The top 10 drugs losing US exclusivity in 2026
Mar 16, 2026 3:00am
Lilly, Pfizer-Sciwind, Astellas—Fierce Pharma Asia
Mar 13, 2026 8:05am
Merck KGaA expects Mavenclad generics to deal serious blow in US
Mar 5, 2026 11:30am
Ireland's drug production hub status intact amid US trade tumult
Mar 3, 2026 4:27pm
